Prostaglandin E2 - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509243360

Publication Date:

September 9, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Prostaglandin E2 (PGE2), also known as dinoprostone, is a naturally occurring prostaglandin with oxytocic properties that is used as a medication.
The global market for Prostaglandin E2 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Dinoprostone is used in labor induction, bleeding after delivery, termination of pregnancy, and in newborn babies to keep the ductus arteriosus open. In babies it is used in those with congenital heart defects until surgery can be carried out. It is also used to manage gestational trophoblastic disease. It may be used within the vagina or by injection into a vein.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostaglandin E2, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prostaglandin E2 by region & country, by Type, and by Application.
The Prostaglandin E2 market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin E2.
麻豆原创 Segmentation
By Company
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Segment by Type:
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segment by Application
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prostaglandin E2 manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Prostaglandin E2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Prostaglandin E2 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Prostaglandin E2 Product Introduction
1.2 Global Prostaglandin E2 麻豆原创 Size Forecast
1.3 Prostaglandin E2 麻豆原创 Trends & Drivers
1.3.1 Prostaglandin E2 Industry Trends
1.3.2 Prostaglandin E2 麻豆原创 Drivers & Opportunity
1.3.3 Prostaglandin E2 麻豆原创 Challenges
1.3.4 Prostaglandin E2 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prostaglandin E2 Players Revenue Ranking (2023)
2.2 Global Prostaglandin E2 Revenue by Company (2019-2024)
2.3 Key Companies Prostaglandin E2 Manufacturing Base Distribution and Headquarters
2.4 Key Companies Prostaglandin E2 Product Offered
2.5 Key Companies Time to Begin Mass Production of Prostaglandin E2
2.6 Prostaglandin E2 麻豆原创 Competitive Analysis
2.6.1 Prostaglandin E2 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Prostaglandin E2 Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostaglandin E2 as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Low Purity(Below 97%)
3.1.2 Purity(Above 97% and Below 99%)
3.1.3 High Purity(Above 99%)
3.1.4 Others
3.2 Global Prostaglandin E2 Sales Value by Type
3.2.1 Global Prostaglandin E2 Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prostaglandin E2 Sales Value, by Type (2019-2030)
3.2.3 Global Prostaglandin E2 Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer Treatment
4.1.2 Neurological Treatment
4.1.3 Endocrinological Treatment
4.1.4 Others
4.2 Global Prostaglandin E2 Sales Value by Application
4.2.1 Global Prostaglandin E2 Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prostaglandin E2 Sales Value, by Application (2019-2030)
4.2.3 Global Prostaglandin E2 Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Prostaglandin E2 Sales Value by Region
5.1.1 Global Prostaglandin E2 Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prostaglandin E2 Sales Value by Region (2019-2024)
5.1.3 Global Prostaglandin E2 Sales Value by Region (2025-2030)
5.1.4 Global Prostaglandin E2 Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Prostaglandin E2 Sales Value, 2019-2030
5.2.2 North America Prostaglandin E2 Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Prostaglandin E2 Sales Value, 2019-2030
5.3.2 Europe Prostaglandin E2 Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Prostaglandin E2 Sales Value, 2019-2030
5.4.2 Asia Pacific Prostaglandin E2 Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Prostaglandin E2 Sales Value, 2019-2030
5.5.2 South America Prostaglandin E2 Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prostaglandin E2 Sales Value, 2019-2030
5.6.2 Middle East & Africa Prostaglandin E2 Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prostaglandin E2 Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prostaglandin E2 Sales Value
6.3 United States
6.3.1 United States Prostaglandin E2 Sales Value, 2019-2030
6.3.2 United States Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prostaglandin E2 Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prostaglandin E2 Sales Value, 2019-2030
6.4.2 Europe Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prostaglandin E2 Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prostaglandin E2 Sales Value, 2019-2030
6.5.2 China Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prostaglandin E2 Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prostaglandin E2 Sales Value, 2019-2030
6.6.2 Japan Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prostaglandin E2 Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prostaglandin E2 Sales Value, 2019-2030
6.7.2 South Korea Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prostaglandin E2 Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prostaglandin E2 Sales Value, 2019-2030
6.8.2 Southeast Asia Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prostaglandin E2 Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prostaglandin E2 Sales Value, 2019-2030
6.9.2 India Prostaglandin E2 Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prostaglandin E2 Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 R&D Systems
7.1.1 R&D Systems Profile
7.1.2 R&D Systems Main Business
7.1.3 R&D Systems Prostaglandin E2 Products, Services and Solutions
7.1.4 R&D Systems Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.1.5 R&D Systems Recent Developments
7.2 Abcam
7.2.1 Abcam Profile
7.2.2 Abcam Main Business
7.2.3 Abcam Prostaglandin E2 Products, Services and Solutions
7.2.4 Abcam Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.2.5 Abcam Recent Developments
7.3 Stemgent
7.3.1 Stemgent Profile
7.3.2 Stemgent Main Business
7.3.3 Stemgent Prostaglandin E2 Products, Services and Solutions
7.3.4 Stemgent Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.3.5 Cayman Chemical Recent Developments
7.4 Cayman Chemical
7.4.1 Cayman Chemical Profile
7.4.2 Cayman Chemical Main Business
7.4.3 Cayman Chemical Prostaglandin E2 Products, Services and Solutions
7.4.4 Cayman Chemical Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.4.5 Cayman Chemical Recent Developments
7.5 Santa Cruz Biotechnology
7.5.1 Santa Cruz Biotechnology Profile
7.5.2 Santa Cruz Biotechnology Main Business
7.5.3 Santa Cruz Biotechnology Prostaglandin E2 Products, Services and Solutions
7.5.4 Santa Cruz Biotechnology Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.5.5 Santa Cruz Biotechnology Recent Developments
7.6 STEMCELL Technologies
7.6.1 STEMCELL Technologies Profile
7.6.2 STEMCELL Technologies Main Business
7.6.3 STEMCELL Technologies Prostaglandin E2 Products, Services and Solutions
7.6.4 STEMCELL Technologies Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.6.5 STEMCELL Technologies Recent Developments
7.7 AbMole Bioscience
7.7.1 AbMole Bioscience Profile
7.7.2 AbMole Bioscience Main Business
7.7.3 AbMole Bioscience Prostaglandin E2 Products, Services and Solutions
7.7.4 AbMole Bioscience Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.7.5 AbMole Bioscience Recent Developments
7.8 Bio-Techne
7.8.1 Bio-Techne Profile
7.8.2 Bio-Techne Main Business
7.8.3 Bio-Techne Prostaglandin E2 Products, Services and Solutions
7.8.4 Bio-Techne Prostaglandin E2 Revenue (US$ Million) & (2019-2024)
7.8.5 Bio-Techne Recent Developments
8 Industry Chain Analysis
8.1 Prostaglandin E2 Industrial Chain
8.2 Prostaglandin E2 Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prostaglandin E2 Sales Model
8.5.2 Sales Channel
8.5.3 Prostaglandin E2 Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.